These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21345167)

  • 1. The early involvement of the innate immunity in the pathogenesis of late-onset Alzheimer's disease: neuropathological, epidemiological and genetic evidence.
    Eikelenboom P; Veerhuis R; van Exel E; Hoozemans JJ; Rozemuller AJ; van Gool WA
    Curr Alzheimer Res; 2011 Mar; 8(2):142-50. PubMed ID: 21345167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immunity and the etiology of late-onset Alzheimer's disease.
    Eikelenboom P; van Exel E; Veerhuis R; Rozemuller AJ; van Gool WA; Hoozemans JJ
    Neurodegener Dis; 2012; 10(1-4):271-3. PubMed ID: 22261470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroinflammation - an early event in both the history and pathogenesis of Alzheimer's disease.
    Eikelenboom P; van Exel E; Hoozemans JJ; Veerhuis R; Rozemuller AJ; van Gool WA
    Neurodegener Dis; 2010; 7(1-3):38-41. PubMed ID: 20160456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer's disease.
    Eikelenboom P; Hoozemans JJ; Veerhuis R; van Exel E; Rozemuller AJ; van Gool WA
    Alzheimers Res Ther; 2012 Jun; 4(3):15. PubMed ID: 22647384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antimicrobial protection hypothesis of Alzheimer's disease.
    Moir RD; Lathe R; Tanzi RE
    Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroinflammation in Alzheimer's disease and prion disease.
    Eikelenboom P; Bate C; Van Gool WA; Hoozemans JJM; Rozemuller JM; Veerhuis R; Williams A
    Glia; 2002 Nov; 40(2):232-239. PubMed ID: 12379910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pro-inflammatory cytokines in Alzheimer's disease].
    Stamouli EC; Politis AM
    Psychiatriki; 2016; 27(4):264-275. PubMed ID: 28114090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate Immunity Fights Alzheimer's Disease.
    Guillot-Sestier MV; Doty KR; Town T
    Trends Neurosci; 2015 Nov; 38(11):674-681. PubMed ID: 26549882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease.
    Šimić G; Španić E; Langer Horvat L; Hof PR
    Prog Mol Biol Transl Sci; 2019; 168():99-145. PubMed ID: 31699331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation.
    Potter H; Wefes IM; Nilsson LN
    Neurobiol Aging; 2001; 22(6):923-30. PubMed ID: 11755000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological aspects of alzheimer's disease: therapeutic implications.
    Hoozemans JJ; Rozemuller AJ; Veerhuis R; Eikelenboom P
    BioDrugs; 2001; 15(5):325-37. PubMed ID: 11437695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease.
    van Exel E; Eikelenboom P; Comijs H; Frölich M; Smit JH; Stek ML; Scheltens P; Eefsting JE; Westendorp RG
    Arch Gen Psychiatry; 2009 Nov; 66(11):1263-70. PubMed ID: 19884614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross Talk Between Brain Innate Immunity and Serotonin Signaling Underlies Depressive-Like Behavior Induced by Alzheimer's Amyloid-β Oligomers in Mice.
    Ledo JH; Azevedo EP; Beckman D; Ribeiro FC; Santos LE; Razolli DS; Kincheski GC; Melo HM; Bellio M; Teixeira AL; Velloso LA; Foguel D; De Felice FG; Ferreira ST
    J Neurosci; 2016 Nov; 36(48):12106-12116. PubMed ID: 27903721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors.
    Salminen A; Ojala J; Kauppinen A; Kaarniranta K; Suuronen T
    Prog Neurobiol; 2009 Feb; 87(3):181-94. PubMed ID: 19388207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment.
    Serpente M; Bonsi R; Scarpini E; Galimberti D
    Neuroimmunomodulation; 2014; 21(2-3):79-87. PubMed ID: 24557039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits.
    Scholtzova H; Do E; Dhakal S; Sun Y; Liu S; Mehta PD; Wisniewski T
    J Neurosci; 2017 Jan; 37(4):936-959. PubMed ID: 28123027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.
    Dudal S; Krzywkowski P; Paquette J; Morissette C; Lacombe D; Tremblay P; Gervais F
    Neurobiol Aging; 2004 Aug; 25(7):861-71. PubMed ID: 15212840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease: Innate immunity gone awry?
    VanItallie TB
    Metabolism; 2017 Apr; 69S():S41-S49. PubMed ID: 28129888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroinflammatory perspectives on the two faces of Alzheimer's disease.
    Eikelenboom P; van Gool WA
    J Neural Transm (Vienna); 2004 Mar; 111(3):281-94. PubMed ID: 14991455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology.
    Hoozemans JJ; Veerhuis R; Rozemuller JM; Eikelenboom P
    CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):57-67. PubMed ID: 21143138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.